Menopause News

Postmenopausal women with vulvovaginal atrophy treated with intravaginal prasterone for at least 12 weeks were nearly 50% less likely to develop a urinary tract infection compared with untreated women, researchers reported in Menopause.

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.

Use of menopausal hormone therapy among midlife active-duty servicewomen in the U.S. is twice as high as the general population but lower than women veterans, suggesting those who may derive the most benefit from HT are not receiving it.

More than 45% of midlife women are diagnosed with several common conditions in addition to menopausal symptoms and data show Black women and those living in high deprivation areas are disproportionately affected, researchers reported.

Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or very severe hot flashes, though researchers found no direct link between the two conditions, data show.

Heterosexual midlife women veterans reported more sexual dysfunction and impact from vaginal symptoms and were less likely to be sexually active compared with sexual minority counterparts, according to findings published in Menopause.

For the 8th year in a row, the Mediterranean diet has been named the best overall diet by the editors of U.S. News and World Report, the company announced.

Anogenital lichen sclerosus can lead to permanent anatomical changes and sexual discomfort in women, highlighting a need for long-term follow-up and high treatment adherence, the latter of which is lacking, according to a study.

The FDA added a boxed warning to highlight known risk for rare but serious liver injury associated with the use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, according to an agency press release.